Cargando…
Therapy Development by Genome Editing of Hematopoietic Stem Cells
Accessibility of hematopoietic stem cells (HSCs) for the manipulation and repopulation of the blood and immune systems has placed them at the forefront of cell and gene therapy development. Recent advances in genome-editing tools, in particular for clustered regularly interspaced short palindromic r...
Autores principales: | Koniali, Lola, Lederer, Carsten W., Kleanthous, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231983/ https://www.ncbi.nlm.nih.gov/pubmed/34198536 http://dx.doi.org/10.3390/cells10061492 |
Ejemplares similares
-
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
por: Papaioannou, Nikoletta Y., et al.
Publicado: (2023) -
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies
por: Lederer, Carsten W., et al.
Publicado: (2022) -
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
por: Papasavva, Panayiota, et al.
Publicado: (2019) -
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
por: Psatha, Nikoletta, et al.
Publicado: (2022) -
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
por: Anurogo, Dito, et al.
Publicado: (2021)